1-3 of 3
Jinsong He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Kaiqi Liu, Xiaohui Suo, Guanchen Bai, Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qiuling Li, Bo Hu, Yingchang Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4272.
https://doi.org/10.1182/blood-2023-179009
Published: 2023
Journal Articles

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qi Wang, Qiuling Li, Bo Hu, Kaiqi Liu, Yingchang Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2895.
https://doi.org/10.1182/blood-2023-179087
Published: 2023
Journal Articles

Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis

Yuhong Shi, Yumi Tohyama, Tomomi Kadono, Jinsong He, S. M. Shahjahan Miah, Ryoichi Hazama, Chisato Tanaka, Kaoru Tohyama, Hirohei Yamamura
Journal: Blood
Blood (2006) 107 (11): 4554–4562.
https://doi.org/10.1182/blood-2005-09-3616
Published: 2006